MAP4K4 inhibition promotes survival of human stem cell-derived cardiomyocytes and reduces infarct size in vivo
Autor Principal: | |
---|---|
Formato: | Journal article |
Publicado: |
Elsevier
2019
|
Autor Principal: | |
---|---|
Formato: | Journal article |
Publicado: |
Elsevier
2019
|